ADVANCES IN TREATMENT OF TYPE-II DIABETES-MELLITUS IN THE ELDERLY

被引:0
|
作者
HENRY, RR [1 ]
EDELMAN, SV [1 ]
机构
[1] VET ADM MED CTR,ENDOCRINE METAB CLIN,SAN DIEGO,CA 92161
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Elderly diabetic patients are prone to the acute and subacute consequences of hyperglycemia, which can adversely affect health, well being, and quality of life. Every elderly patient with diabetes should be offered an individualized treatment plan, consisting of education, dietary counseling, and an exercise program. If fasting and postprandial glucose levels do not stay consistently in the desired range, then an oral hypoglycemic agent should be instituted at the lowest possible dose. When the oral hypoglycemic agent fails, it may be possible to achieve good glycemic control with the addition of insulin. Recent developments in insulin administration can optimize glycemic benefits and reduce potential adverse effects.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 50 条
  • [31] EPIDEMIOLOGY OF THE DIABETES-MELLITUS, NONDEPENDENT ON INSULIN (TYPE-II)
    PANZRAM, G
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1986, 41 (17): : 1325 - 1328
  • [32] SYMPTOMS OF DEPRESSION IN PATIENTS WITH TYPE-II DIABETES-MELLITUS
    LEEDOM, LJ
    MEEHAN, WP
    PROCCI, WR
    ZEIDLER, A
    PSYCHOSOMATIC MEDICINE, 1989, 51 (02): : 265 - 265
  • [33] RHEOLOGICAL LEUKOCYTE INDEXES IN DIABETES-MELLITUS TYPE-II
    PEREGO, MA
    DANESE, C
    VOLPE, MS
    ZAVATTARO, E
    CALISI, L
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1992, 41 (10): : A75 - A80
  • [34] RHEOLOGICAL ABNORMALITIES IN UNCONTROLLED TYPE-II DIABETES-MELLITUS
    SHAW, S
    BAUERSACHS, R
    ZEIDLER, A
    LEBOVITZ, Y
    MEISELMAN, H
    CLINICAL RESEARCH, 1987, 35 (01): : A158 - A158
  • [35] INABILITY TO STOP INSULIN IN TYPE-II DIABETES-MELLITUS
    FRAZIER, LM
    MULROW, CD
    HARRIS, RT
    BROWN, JT
    CLINICAL RESEARCH, 1985, 33 (02): : A720 - A720
  • [36] IS TYPE-II DIABETES-MELLITUS (NIDDM) A SURGICAL DISEASE
    PORIES, WJ
    MACDONALD, KG
    FLICKINGER, EG
    DOHM, GL
    SINHA, MK
    BARAKAT, HA
    MAY, HJ
    KHAZANIE, P
    SWANSON, MS
    MORGAN, E
    LEGGETTFRAZIER, N
    LONG, SD
    BROWN, BM
    OBRIEN, K
    CARO, JF
    BERRY, RE
    JONES, RS
    ANNALS OF SURGERY, 1992, 215 (06) : 633 - 643
  • [37] METABOLIC EFFECTS OF STANOZOLOL IN TYPE-II DIABETES-MELLITUS
    SMALL, M
    FORBES, CD
    MACCUISH, AC
    HORMONE AND METABOLIC RESEARCH, 1986, 18 (09) : 647 - 648
  • [38] DILTIAZEM IN HYPERTENSIVE PATIENTS WITH TYPE-II DIABETES-MELLITUS
    ANDREN, L
    HOGLUND, P
    DOTEVALL, A
    EGGERTSEN, R
    SVENSSON, A
    OLSON, SO
    WADENVIK, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (11): : G114 - G120
  • [39] SYMPTOMS OF DEPRESSION IN PATIENTS WITH TYPE-II DIABETES-MELLITUS
    LEEDOM, L
    MEEHAN, WP
    PROCCI, W
    ZEIDLER, A
    PSYCHOSOMATICS, 1991, 32 (03) : 280 - 286
  • [40] EFFECT OF TYPE-II DIABETES-MELLITUS ON THEOPHYLLINE ELIMINATION
    ADITHAN, C
    SRIRAM, G
    SWAMINATHAN, RP
    KRISHNAN, M
    BAPNA, JS
    CHANDRASEKAR, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1989, 27 (05) : 258 - 260